We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oncimmune Holdings Plc | LSE:ONC | London | Ordinary Share | GB00BYQ94H38 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.10 | 0.63% | 15.85 | 10,118 | 16:35:24 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 15.00 | 16.70 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Medical Laboratories | 2.11M | 4.1M | 0.0554 | 2.84 | 11.68M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:28:01 | O | 118 | 16.90 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 09/9/2024 | 11:42 | ALNC |  Oncimmune expects "substantial" revenue growth following contract wins |
| 09/9/2024 | 07:00 | UK RNS | Oncimmune Holdings PLC Trading Update |
| 02/9/2024 | 17:35 | ALNC | Oncimmune Holdings agrees new contract valued at USD700,000 |
| 02/9/2024 | 07:00 | UK RNS | Oncimmune Holdings PLC Contract Win |
| 09/8/2024 | 17:15 | ALNC | TRADING UPDATES: Tan Delta signs contract; Earnz loss widens |
| 09/8/2024 | 07:00 | UK RNS | Oncimmune Holdings PLC US$1.5m Contract Win with Top 10 Pharma Company |
| 24/6/2024 | 11:18 | UK RNS | Oncimmune Holdings PLC Holding(s) in Company |
| 17/6/2024 | 14:30 | UK RNS | Oncimmune Holdings PLC Holding(s) in Company |
| 29/5/2024 | 17:45 | UK RNS | Oncimmune Holdings PLC Holding(s) in Company |
| 21/5/2024 | 16:27 | ALNC | EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss |
Oncimmune (ONC) Share Charts1 Year Oncimmune Chart |
|
1 Month Oncimmune Chart |
Intraday Oncimmune Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 09/9/2024 | 14:43 | Oncimmune (ONC) cancer test diagnoses '80pc of tumours' early, savin | 296 |
| 23/1/2018 | 07:49 | Oncimmune (ONC) could save millions of lives | 2 |
| 20/2/2001 | 00:30 | Online Classics plc | 1 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 06/10/2024 09:20 by Oncimmune Daily Update Oncimmune Holdings Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker ONC. The last closing price for Oncimmune was 15.75p.Oncimmune currently has 74,142,147 shares in issue. The market capitalisation of Oncimmune is £11,677,388. Oncimmune has a price to earnings ratio (PE ratio) of 2.84. This morning ONC shares opened at - |
Posted at 09/9/2024 11:38 by base7 ONC had strong update today which Martin G will be very pleased with .Todays Lab deal maybe positive medium term but short term relatively immaterial & I suspect there will be more news (Results at least )before Marks presentation on 24th .Lack of volume & share price action suggests that insiders are aware of fund raise discussions -let’s see ! |
Posted at 09/9/2024 07:44 by brummy_git All the details & commentary wrt today's positive trading update from ONC here |
Posted at 22/8/2024 14:21 by kingston78 I have noticed that the share always doubles from its previous low point. The recent low point was 10 p. It has since risen for two consecutive weeks to 17 p now. By reference to my observation it should reach 20 p. As a matter of fact the MACD is about to cut upwards, signalling a rise. |
Posted at 12/8/2024 15:28 by jaknife LOL!This share is a pile of poo and desperately needs to raise funds. See three posts up ^^^. JakNife |
Posted at 12/8/2024 14:13 by kingston78 This share is a chart buy. Next stop is 20 p. |
Posted at 21/5/2024 18:03 by jaknife The interim numbers are absolutely awful, this looks hopelessly uninvestable!P&L * Revenues are trivial at just £1.2m, businesses this small simply shouldn't be listed! * Gross profit down materially as gross margins drop from 69% to just 38% * Significant admin expenses and finance costs push the P&L into a £1.1m loss! Balance sheet * Net equity is negative at -£1.3m * Tangible net equity is -£3.3m! * There's £5.2m of debt! Just £0.9m of cash. Cash Flow * Poor, they burnt £2.2m in H1 alone and obviously need to raise cash They need to do a recap raise to restore the balance sheet but why bother? It's impossible to justify the current market cap of £18.5m. JakNife |
Posted at 12/10/2023 08:19 by brummy_git Encouraging new developments from IPR rich life science firm Oncimmune.All the details here. |
Posted at 31/5/2023 11:15 by eva_1989 I dont know what Trek from LSE smoking but i badly need same ;)He thought to pump before open so that he can sell to others... Hi R00st3R, I think todays interims answer your questions. All good at ONC. Well actually very good! Should be a cracking day today! Pity some of the revs got delayed but there is a line of sight and perhaps most importantly a change in sentiment. Wish I could buy more at this price! Usual caveats Trek |
Posted at 31/5/2023 09:33 by brummy_git H1'23 results out today from Oncimmune. All the details here. |
Posted at 22/5/2023 09:26 by brummy_git Very positive M&A and contract news from global immunodiagnostics group Oncimmune today.All the details here. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
